Public-registry site landscape for NCT05066698, a Persistent Corneal Epithelial Defect study sponsored by Noveome Biotherapeutics, formerly Stemnion. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05066698 (registry record) |
| Sponsor | Noveome Biotherapeutics, formerly Stemnion |
| Condition(s) | Persistent Corneal Epithelial Defect |
| Phase | PHASE2 |
| Listed sites | 31 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05066698 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →